7-100633010-G-C

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1

The NM_003227.4(TFR2):​c.840C>G​(p.Phe280Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000429 in 1,613,734 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. F280F) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00038 ( 0 hom., cov: 30)
Exomes 𝑓: 0.00043 ( 0 hom. )

Consequence

TFR2
NM_003227.4 missense

Scores

1
2
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:1

Conservation

PhyloP100: -0.386

Publications

6 publications found
Variant links:
Genes affected
TFR2 (HGNC:11762): (transferrin receptor 2) This gene encodes a single-pass type II membrane protein, which is a member of the transferrin receptor-like family. This protein mediates cellular uptake of transferrin-bound iron, and may be involved in iron metabolism, hepatocyte function and erythrocyte differentiation. Mutations in this gene have been associated with hereditary hemochromatosis type III. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, May 2011]
TFR2 Gene-Disease associations (from GenCC):
  • hemochromatosis type 3
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.055341333).
BP6
Variant 7-100633010-G-C is Benign according to our data. Variant chr7-100633010-G-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 287086.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000381 (58/152232) while in subpopulation AMR AF = 0.00137 (21/15288). AF 95% confidence interval is 0.00092. There are 0 homozygotes in GnomAd4. There are 24 alleles in the male GnomAd4 subpopulation. Median coverage is 30. This position passed quality control check.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003227.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TFR2
NM_003227.4
MANE Select
c.840C>Gp.Phe280Leu
missense
Exon 6 of 18NP_003218.2
TFR2
NM_001206855.3
c.327C>Gp.Phe109Leu
missense
Exon 3 of 15NP_001193784.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TFR2
ENST00000223051.8
TSL:1 MANE Select
c.840C>Gp.Phe280Leu
missense
Exon 6 of 18ENSP00000223051.3
TFR2
ENST00000462107.1
TSL:5
c.840C>Gp.Phe280Leu
missense
Exon 7 of 19ENSP00000420525.1
TFR2
ENST00000431692.5
TSL:5
c.840C>Gp.Phe280Leu
missense
Exon 6 of 16ENSP00000413905.1

Frequencies

GnomAD3 genomes
AF:
0.000381
AC:
58
AN:
152114
Hom.:
0
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00138
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000485
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000411
AC:
102
AN:
248248
AF XY:
0.000385
show subpopulations
Gnomad AFR exome
AF:
0.0000638
Gnomad AMR exome
AF:
0.00116
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000510
Gnomad OTH exome
AF:
0.000658
GnomAD4 exome
AF:
0.000434
AC:
635
AN:
1461502
Hom.:
0
Cov.:
33
AF XY:
0.000419
AC XY:
305
AN XY:
727066
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33476
American (AMR)
AF:
0.00114
AC:
51
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53072
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.000478
AC:
531
AN:
1111982
Other (OTH)
AF:
0.000861
AC:
52
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
45
90
134
179
224
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000381
AC:
58
AN:
152232
Hom.:
0
Cov.:
30
AF XY:
0.000322
AC XY:
24
AN XY:
74420
show subpopulations
African (AFR)
AF:
0.0000722
AC:
3
AN:
41568
American (AMR)
AF:
0.00137
AC:
21
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5162
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10600
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000485
AC:
33
AN:
68006
Other (OTH)
AF:
0.00
AC:
0
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000445
Hom.:
0
Bravo
AF:
0.000450
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.000814
AC:
7
ExAC
AF:
0.000354
AC:
43
EpiCase
AF:
0.000382
EpiControl
AF:
0.000356

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Hemochromatosis type 3 Uncertain:1
Jan 14, 2020
Natera, Inc.
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

not provided Uncertain:1
Mar 23, 2016
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Hereditary hemochromatosis Benign:1
Nov 18, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.91
BayesDel_addAF
Benign
-0.31
T
BayesDel_noAF
Benign
-0.26
CADD
Benign
16
DANN
Benign
0.91
DEOGEN2
Benign
0.24
T
Eigen
Benign
-0.87
Eigen_PC
Benign
-0.84
FATHMM_MKL
Benign
0.33
N
LIST_S2
Benign
0.84
T
M_CAP
Benign
0.023
T
MetaRNN
Benign
0.055
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.1
L
PhyloP100
-0.39
PrimateAI
Uncertain
0.69
T
PROVEAN
Uncertain
-3.9
D
REVEL
Benign
0.21
Sift
Benign
0.080
T
Sift4G
Benign
0.13
T
Polyphen
0.020
B
Vest4
0.71
MutPred
0.78
Loss of catalytic residue at F280 (P = 0.0231)
MVP
0.28
MPC
0.43
ClinPred
0.055
T
GERP RS
-3.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.58
gMVP
0.78
Mutation Taster
=51/49
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs151198873; hg19: chr7-100230633; API